Summary Comments
- Most frequently detected viruses in December (all age groups):
- Rhino/Enterovirus: 24.6%
- Rhinovirus: 16.7%
- Parainfluenza 1–4: 8.1%
- SARS-CoV-2: 7.86%
- Epidemiological Week 1–52:
- SARS-CoV-2: Stable at ~7.9% in week 52
- Influenza A: Slight increase from 0.7% (week 49) to 1.9% (week 52)
- Influenza B: Peaked at 11.1% (week 46), declined to 7% (week 52)
Respiratory Viral Multiplex PCR and SARS-CoV-2 PCR: All Age Groups
November 2023:
- Rhino/Enterovirus: 30.4%
- Rhinovirus: 25.2%
- Parainfluenza 1–4: 8.6%
- SARS-CoV-2: 6.8%
- Influenza A: 2.6%
- Influenza B: 2.8%
- Adenovirus: 6.5%
- RSV: 1.0%
- Coronavirus (non-SARS-CoV-2): 2.5%
- Metapneumovirus: 9.1%
December 2023:
- Rhino/Enterovirus: 24.6%
- Rhinovirus: 16.7%
- Parainfluenza 1–4: 8.1%
- SARS-CoV-2: 7.86%
- Influenza A: 1.9%
- Influenza B: 1.4%
- Adenovirus: 7.5%
- RSV: 1.6%
- Coronavirus (non-SARS-CoV-2): 2.7%
- Metapneumovirus: 8.1%
Atypical Bacterial Pathogens (Weeks 1–52)
Detected Cases:
- B. pertussis: 601 cases
- M. pneumoniae: 1,683 cases (peak: week 25, 72 cases)
B. pertussis Age Distribution:
- 0–6 months: 25%
- 6–12 years: 23%
- 1–5 years: 19.5%
18 years: 23%
M. pneumoniae Age Distribution:
- 1–5 years: 38%
- 6–12 years: 29%
Paediatric Respiratory Viral Multiplex PCR Data (Ages 0–12)
<1 Year Age Group
November 2023:
- Rhino/Enterovirus: 45%
- Rhinovirus: 29%
- Parainfluenza 1–4: 13.6%
- Adenovirus: 11.7%
- RSV: 3.4%
- SARS-CoV-2: 9.3%
- Influenza A: 4.3%
- Influenza B: 0.2%
- Coronavirus: 3.2%
December 2023:
- Rhino/Enterovirus: 36.2%
- Rhinovirus: 25.5%
- Parainfluenza 1–4: 11.8%
- Adenovirus: 11.7%
- RSV: 4%
- SARS-CoV-2: 11.8%
- Influenza A: 5.8%
- Influenza B: 0.5%
- Coronavirus: 3.3%
1–5 Year Age Group
November 2023:
- Rhino/Enterovirus: 52%
- Rhinovirus: 40%
- Adenovirus: 15.6%
- Enterovirus: 15.3%
- SARS-CoV-2: 14.7%
- Influenza A: 17.3%
- Influenza B: 0.8%
- RSV: 2.4%
- Coronavirus: 10.9%
December 2023:
- Rhino/Enterovirus: 43.6%
- Rhinovirus: 28.2%
- Adenovirus: 15.6%
- Enterovirus: 15.3%
- SARS-CoV-2: 14.6%
- Influenza A: 15.3%
- Influenza B: 1.1%
- RSV: 3%
- Coronavirus: 10.1%
6–12 Year Age Group
November 2023:
- Rhino/Enterovirus: 33.9%
- Rhinovirus: 34.9%
- Influenza B: 18.2%
- SARS-CoV-2: 3.7%
- Influenza A: 3.8%
- Adenovirus: 6.1%
- RSV: 0.4%
- Coronavirus: 6.7%
December 2023:
- Rhino/Enterovirus: 29%
- Rhinovirus: 13.3%
- Influenza B: 12.9%
- SARS-CoV-2: 3.4%
- Influenza A: 1.3%
- Adenovirus: 6.1%
- RSV: 0.6%
- Coronavirus: 6.7%
Highlights by Age Group (December 2023)
- <1 year:
- Rhino/Enterovirus (36.2%), Rhinovirus (25.5%), Parainfluenza 1–4 (11.8%), Adenovirus (11.7%)
- 1–5 years:
- Rhino/Enterovirus (43.6%), Rhinovirus (28.2%), Adenovirus (15.6%), Enterovirus (15.3%)
- 6–12 years:
- Rhino/Enterovirus (29%), Rhinovirus (13.3%), Influenza B (12.9%)
Continue Reading